2.Preliminary studies of the toxcicity of staphylococcal enterotoxin A liposomes
Zhiyu LI ; Min SU ; Sheng HE ; Jiesho LI
Journal of Medical Postgraduates 2003;0(04):-
Objective: The bacterial superantigen staphylococcal enterotoxin A (SEA) has the potent ability of inducing T cell activation as well as directing activated T cells to kill tumour cells. However, its application in the tumour treatment is limited due to its systemic immune activation.In order to minimize its side effects SEA liposomes is prepared and their toxcicity in vivo is investigated . Methods: SEA liposomes were prepared by the method of reverse-phase evaporation . SEA liposomes were administered intravenously . In vivo the toxcicity of SEA liposomes was investigated by the measurement of blood pressure, colonic temperature and breath rate of New Zealand rabbits. Mice plasma TNF-? and IFN-? level were determined by ELISA . Results:After iv administration of SEA liposomes, significant reduction of mice plasma TNF-? and IFN-? level was observerd. As compared to free SEA, liposomal SEA had less effect on blood pressure, colonic temperature and breath rate of the rabbits. Conclusion:SEA Liposomes had relatively low toxicity. These advantage was probably due to its lower systemic immune activation effect and inducing consequent lower systemic TNF-? and IFN-? level.
3.A new cyclic diarylheptanoid from the bark of Myrica rubra.
Sheng-nan SHEN ; Fang-bo XIA ; He LI ; Ya-min LIU ; Rui-le PAN
Acta Pharmaceutica Sinica 2015;50(6):746-748
To study the chemical constituents from the bark of Myrica rubra, fourteen compounds were isolated from the methanolic extract using various chromatographic techniques, including silica gel, Sephadex LH-20 and preparative HPLC. Their structures were identified on the basis of chemical properties and spectroscopic data, as 3, 5-dimethoxy-4-hydroxymyricanol (1), myricanol (2), myricanone (3), myricanol 11-sulfate (4), myricitrin (5), quercetin (6), quercetin-3-rhamnoside (7), tamarixol (8), uvaol (9), ursolic acid (10), taraxerol (11), myricadiol (12), β-sitosterol (13) and β-daucosterol (14). Among them, compound 1 is a new compound, named as 3, 5-dimethoxy-4-hydroxymyricanol, compounds 8, 9 were isolated from the genus Myrica for the first time.
Diarylheptanoids
;
chemistry
;
isolation & purification
;
Myrica
;
chemistry
;
Phytochemicals
;
chemistry
;
isolation & purification
;
Plant Bark
;
chemistry
4.Expression of plasmacytoid dendritic cells in peripheral blood and renal tissues in children with Henoch-Sch(o)nlein purpura
Juan WANG ; Guimei GUO ; Min XIA ; Lin ZHENG ; Sheng HAO ; Wenyan HUANG ; Weixun HE
Chinese Journal of Applied Clinical Pediatrics 2014;29(5):338-341
Objective To investigate the expression and distribution of plasmacytoid dendritic cells(pDC) in peripheral blood and renal tissues in children with Henoch-SchSnlein purpura(HSP),and explore the role of pDCs in the pathogenesis of Henoch-Schtnlein purpura nephritis(HSPN).Methods Among the 40 children with HSP,28 cases were in the active phase(renal biopsy performed in 8 cases of them) and the other 12 in remission phase.Peripheral blood mononuclear cells were isolated,and the expression of pDC was detected by flow cytometry.The normal control group was established (n =15).Total RNA of peripheral blood was extracted and transcripted into cDNA.Sybr green dye based real-time quantitative PCR method was used to compare the expression(indicated as 2-△Ct value) of CXC motif chemokine 10 (CXCL10),CC chemokine ligand 5 (CCL5),chemokine CXC subfamily receptor 3 (CXCR3),CC chemokine receptor 5 (CCR5) in children with HSP and those in the controls.Immunohistochemistry labeling technique was used to detect the distribution of pDC in renal tissues from renal biopsy,and the normal controls were established (n =3).Results The expression percentage of pDC in peripheral blood in active phase was 0.051 ± 0.039,significantly lower than those in remission phase (0.181 ± 0.082) and the normal controls (0.166 ± 0.079) (P < 0.000 1).Chemokines genes CXCL10 and CCL5 were overexpressed in peripheral blood ceils of acute phase HSP children,but chemokine receptors CXCR3,CCR5 were lowly expressed compared with normal controls.There was almost no expression of pDC in the normal control renal tissues,while pDC was infiltrated in glomeruli of HSPN children.Conclusions The number of pDC and chemokines' expression in peripheral blood is abnormal,and the pathogenesis of nephritis may be involved with the pDC in peripheral blood to migrate to the renal tissues.
5.Safety of modified sputum induction in moderate-to-very severe COPD during exacerbation
Liping WEI ; Shanshan KANG ; Sheng HE ; Min LIN ; Tianhua ZHU ; Weiqiang LIANG ; Fang LI
The Journal of Practical Medicine 2014;(17):2751-2753
Objective To evaluate the safety of modified sputum induction in moderate to very severe COPD during exacerbation. Methods Ninety patients with moderate, severe or very severe COPD during exacerbation (27 with type Ⅰ and Ⅱ respiratory failure,18 with coronary heart disease, 38 with tachycardia) were chosen as research subjects. All the patients underwent induced sputum. During induction , all patients were given electrocardiographic monitoring and pulmonary function check every 5 minutes and FEV1, HR, SpO2 in the process of testing were recorded. Results Ninety patients underwent 224 sputum inductions progress, 222 were safety. Qualified sputum samples were collected for 216 times, sputum induction was successful in 96.43% of occasions. Heart rate rising and SpO2 reducing during sputum induction mainly occurred in the beginning 5 minutes, FEV1 did not change in the whole process. Conclusion Modified sputum induction can be safe through closely monitoring in patients with moderate-to-very severe COPD with exacerbation, even with type Ⅰ or typeⅡ respiratory failure. But the risk of sputum induction will increase if patients with coronary heart disease and tachyarrhythmia, especially within beginning 5 minutes of sputum induction.
6.Microvenular hemangioma: report of a case.
Qian-he LIAO ; Hui-min AN ; Sheng-hua PAN ; Wei-hua LI
Chinese Journal of Pathology 2013;42(7):474-475
Actins
;
metabolism
;
Antigens, CD34
;
metabolism
;
Diagnosis, Differential
;
Female
;
Hemangioma
;
metabolism
;
pathology
;
surgery
;
Hemangiosarcoma
;
pathology
;
Humans
;
Middle Aged
;
Platelet Endothelial Cell Adhesion Molecule-1
;
metabolism
;
Sarcoma, Kaposi
;
pathology
;
Skin Neoplasms
;
metabolism
;
pathology
;
surgery
;
Vimentin
;
metabolism
7.Research on dendritic cells to soak gallbladder carcinoma tissue
Lifeng AN ; Li SHENG ; Ping HE ; Lin SHI ; Guixiang FAN ; Yukang YUAN ; Min LI
Chinese Journal of Immunology 1985;0(03):-
Objective:Explore the dendritic cells to soak gallbladder carcinoma tissue,to explain the relation dendritic cells and tumor immunity.Methods:Adopt immune histochmistry S-P method.Results:The extent of dendritic cells to soak gallbladder carcinoma tissue is not relate to age,gender and types of pathhistology but negative contact with degree of pathological differentiation (P
8.Characteristics of Electrocardiography in Pressure Overload-induced Cardiac Hypertrophy Rats
Yao-Sheng WANG ; Li-Peng HE ; Yi-Hua ZHOU ; Lu-Min XIAO ; Xiao-Shu CHENG ;
Chinese Journal of Hypertension 2006;0(10):-
Objective To analyze the electrocardiography(ECG)data of pressure overload-induced cardiac hy pertrophy rats.Methods Pressure overload cardiac hypertrophy was induced by abdominal aorta constriction. Echocardiogram and heart weight measurement demonstrated the occurrence of cardiac hypertrophy.Standardized ECG parameters of limb and chest were measured and statistically analyzed.Results Two weeks after hypertrophy models were established,echocardiogram showed greater LVPWTd,IVSTd,LVDd.ECG showed that left axis deviation and higher R waves in V_A,V_B,V_C(P
9.Mutations in the epidermal growth factor receptor and targeted therapy of non-small-cell lung cancer.
Ren-Sheng LAI ; Ling XIE ; Long-Shu SHEN ; Ya-Min HE ; Chang-Le ZHU
Chinese Journal of Pathology 2005;34(11):745-746
Antineoplastic Agents
;
therapeutic use
;
Carcinoma, Non-Small-Cell Lung
;
drug therapy
;
genetics
;
Drug Delivery Systems
;
Erlotinib Hydrochloride
;
Female
;
Genes, erbB-1
;
Humans
;
Lung Neoplasms
;
drug therapy
;
genetics
;
Male
;
Mutation
;
Protein Kinase Inhibitors
;
therapeutic use
;
Quinazolines
;
therapeutic use
;
Receptor, Epidermal Growth Factor
;
antagonists & inhibitors
;
genetics
10.Clinical observation of nimotuzumab with chemotherapy in metastatic gastrointestinal tumor patients
Min PANG ; Guohua REN ; Yahong SUN ; Weina HE ; Yuji AN ; Jangze XIN ; Weihua ZHANG ; Pengyuan SONG ; Lijun SHENG
Cancer Research and Clinic 2012;24(7):454-456
ObjectiveTo explore the efficacy and toxicity of nimotuzumab plus chemotherapy in the treatment of metastatic gastrointestinal tumor.MethodsObservationgroup 22 patients with metastatic gastrointestinal tumor with confirmed diagnosis,were treated with nimotuzumab in combination chemotherapy.Nimotuzumab was given 200 mg weekly for at least six weeks. Control group 21 patients with metastatic gastrointestinal tumor with confirmed diagnosis were treated with only chemotherapy.ResultsThe effects of observation group could be observed in 22 patients, the rate of response(RR)was 31.8% (7/22), and the disease control rate (DCR) was 72.7 % (16/22).QOL was improved.The effects of observation group could be observed in 21 patients,RR was 14.3 % (3/21),and the disease control rate was 42.8 % (19/21).DCR and QOL improvements were statistically significant different between the two groups.(x2=3.939,x2=4.250,P<0.05).The two groups had no significant difference in RR and toxicity.ConclusionNimotuzumab in combination with chemotherapy is effective and can improve the disease control rate, toxicity, tolerance,quality of life.